Friday, June 2 Posters Divya Natesan “Differences in real-world pembrolizumab dosing patterns (every 3 weeks versus every 6 weeks) across a large cancer center network” 8 to 11 a.m. Hall A | Abstract 2592 | Board 434 Jingxiao Jin, MD…
Researchers have known that microorganisms in the gut can impact the effectiveness of immunogenic chemotherapies for cancer patients. When studies showed that the same could be true for immune checkpoint inhibitors, it opened the possibility for better treatment options for…
Head and neck cancer accounts for approximately 4% of cancer cases in the U.S. — affecting more than 60,000 people each year. The majority of those diagnosed are over the age of 50, but a rising rate of HPV-associated head…
This month, women’s history was celebrated bringing attention to the remarkable role that women play in society. Here at UPMC Hillman Cancer Center, our Women’s Initiatives Task Force supports and fosters women all throughout the year. They kicked off 2023…
For Women’s History Month, this research Q&A focuses on Kelly Bailey, MD, PhD, and her experience as a female researcher. Dr. Kelly Bailey is a member of the Cancer Biology Program at UPMC Hillman Cancer Center, assistant professor in the…
For Women’s History Month, this research Q&A focuses on Olivera Finn, PhD, and her experience as a female researcher. Dr. Finn is a member of the Cancer Immunology and Immunotherapy Program at UPMC Hillman Cancer Center and distinguished professor in…
According to the American Medical Association, racial and ethnic minorities experience a lower quality of health care, are less likely to receive routine care, and face higher rates of morbidity and mortality than nonminorities. When it comes to cancer patients,…
Researchers at the UPMC Hillman Cancer Center Tumor Microenvironment Center developed a new model that can be used by immunologists to further the understanding of CAR-T cell biology and identified a new possible human CAR-T cell target. The model published…
The University of Pittsburgh was awarded a five-year, $11.2 million grant from the National Institutes of Health (NIH) to support a Head and Neck Cancer Specialized Program of Research Excellence (SPORE) in 2022. The award will be led by Robert…
Steffi Oesterreich, PhD, is a researcher at UPMC Hillman Cancer Center who focuses her work on better understanding how to most effectively treat breast cancers, including invasive lobular carcinoma (ILC) and estrogen receptor-positive (ESR1) breast cancer resistant to hormonal therapies. …
